| Literature DB >> 17438069 |
Jun Y Park1, M Amin Arnaout, Vineet Gupta.
Abstract
The leukocyte-specific integrin CD11b/CD18 plays a key role in the biological function of these cells and represents a validated therapeutic target for inflammatory diseases. Currently, the low affinity interaction between CD11b/CD18 integrin and its respective ligand poses a challenge in the development of cell-based adhesion assays for the high-throughput screening (HTS) environment. Here the authors describe a simple cell-based adhesion assay that can be readily used for HTS for the discovery of functional regulators of CD11b/CD18. The assay consistently produces acceptable Z' values (> 0.5) for HTS. After testing the assay using 2 established blocking antibodies as reference biologicals, the authors performed a proof-of-concept primary screen using a library of 6612 compounds and identified both agonist and antagonist hits.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17438069 PMCID: PMC3075871 DOI: 10.1177/1087057106299162
Source DB: PubMed Journal: J Biomol Screen ISSN: 1087-0571